This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore weekend part time jobs that allow you to earn extra money. Take advantage of your free time to enhance your financial situation.
24,225 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A steep stock drop can force tough choices. This article analyzes why a full exit from Cogent could matter to investo...
Federal rules demanding domestic-made materials for affordable housing funded with federal dollars are slowing projec...
Ethereum has struggled to clear its late-2025 highs, with on-chain data showing a wave of whale selling even as ETF i...
The T3 Financial Crime Unit, supported by tether, tron labs-backed financial partners, says it has frozen over $450 m...
AI-driven forecasts for XRP and Solana diverge by end-2026, leaving investors weighing who could win. The analysis us...
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
Former Fed Chair Jerome Powell makes a pointed defense of central-bank independence at a high-profile ceremony, warni...
Melinda French Gates is directing a major, independent push for women’s health, backing a 215 million-dollar initiati...
Inflation trends keep shifting, and the fed's latest inflation forecast is a key signal for investors. This guide bre...
Bitcoin is within roughly 9,500 blocks of a pivotal activation window that could redraw its governance playbook. The ...